Google search study of orthopaedic peptide questions ranks 300 results on BPC-157 information quality
A cross-sectional analysis of 300 Google search results about orthopaedic peptide therapy, chiefly BPC-157, categorized the most common patient questions and scored website quality, reporting an average JAMA benchmark score of 2.0.
Arthroscopy, sports medicine, and rehabilitation · 2026 · Human observational · n=300 · Human · Published November 10, 2026
This page reports what published studies found. It is not medical advice, no provider-patient relationship is created by reading it, and nothing here is a recommendation to use any compound. Talk with a licensed clinician about your own situation. Read the full disclaimer.
What the study did
This was a human-oriented observational analysis of publicly available internet content rather than a study that enrolled or treated patients; no participants or animals received any compound. The investigators report that three orthopaedic peptide searches were entered into a clean Google Web Search on June 30, 2025, and that the first 100 consecutive results meeting inclusion criteria for each query were included, for 300 total.
Questions appearing under the "People also ask" tab were expanded sequentially. Questions or websites unrelated to orthopaedic peptides and repeat verbatim questions within each query were excluded. The authors sorted questions into one of three Rothwell Classifications with topic subcategories, categorized websites by source, and applied the Journal of the American Medical Association Benchmark Criteria to each website.
What it reported
Most questions fell into the Rothwell Fact category at 61.0%. The most common question topics were Structure/Function at 31.7%, Risks/Complications at 20.7%, and Treatment Comparisons at 9.7%. The least common topics were Specific Activities at 0%, Pain at 0.3%, Longevity of Treatment at 0.7%, and Management at 0.7%.
By source, the most common websites were Commercial at 28.0%, Academic at 18.0%, and Government at 18.0%, with PubMed articles making up 98.1% of Government websites. The authors report an overall average Journal of the American Medical Association score of 2.0, with Government websites scoring highest and making up 48.6% of websites rated 4/4, while Medical Practice and Single Surgeon websites had the lowest scores.
The conclusion states that the most common online patient questions pertain to the structure, function, and risks associated with peptide therapy, and that the quality of the information is heterogeneous. The abstract reports no dose, route, or schedule of BPC-157, because no compound was administered in this work.
Limitations
The analysis captures a single search engine on a single date, June 30, 2025, using three queries, so the results reflect that snapshot of search rankings rather than what any individual reader would see later or elsewhere. There was no comparison group and no clinical outcome of any kind; the unit of analysis was a search result, not a patient.
Website quality was judged with the Journal of the American Medical Association Benchmark Criteria, which assesses disclosure features rather than whether the biological claims on a page are accurate. The abstract reports no funding source or author affiliations, and it provides no information on the efficacy or safety of BPC-157 itself.
Regulatory context
BPC-157, also called body protection compound 157 or pentadecapeptide BPC 157, is not an FDA-approved drug for any use. This status comes from the site's regulatory review and not from the study described here.
Claims and where they come from
Each statement below is followed by the passage of the source record it was checked against.
The authors ran three orthopaedic peptide searches on a single date in a cleared Google Web Search.
“Three orthopaedic peptide searches were entered into a clean Google Web Search on June 30, 2025.”
The sample consisted of 300 search results, 100 per query.
“The first 100 consecutive results meeting inclusion criteria for each query were included (300 total).”
A majority of the questions were classified as fact-seeking.
“Most questions fell into the Rothwell Fact category (61.0%).”
Structure and function questions were the single most common topic, followed by risks and complications.
“Most common question topics were Structure/Function (31.7%), Risks/Complications (20.7%), and Treatment Comparisons (9.7%).”
Commercial sites were the most frequent source category among results.
“The most common websites were Commercial (28.0%), Academic (18.0%), and Government (18.0%).”
The authors describe the overall quality of the online information as uneven.
“The quality of the information is heterogeneous.”
Common questions
Did anyone receive BPC-157 in this study?
No. The abstract describes an analysis of Google search questions and websites about orthopaedic peptide therapy, and it reports no dose, route, or schedule for any compound.
How was website quality measured?
The abstract states that the Journal of the American Medical Association Benchmark Criteria was used to evaluate the quality of each website, with an overall average score of 2.0 reported.
Which sources scored highest and lowest?
The abstract reports that Government websites had the highest score and constituted 48.6% of websites scoring 4/4, while Medical Practice and Single Surgeon websites had the lowest scores.
Does this study say anything about whether BPC-157 works?
No. It reports what questions people ask online and how online sources score on a disclosure-based quality instrument; it reports no clinical outcomes.
Source
- 1.Patients Use Google to Ask Questions About the Structure, Function, and Risks of Peptide Use in Orthopaedic Surgery — Arthroscopy, sports medicine, and rehabilitation (2026)Human observationalhumann=300PMID 43006127DOI 10.1002/ars2.70084